Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | ||||||||||
| Cash from operating activities | -69.26%2.42M | 1.51M | -28.94%2.66M | 43.56%20.66M | 9.07M | 7.86M | 0 | 3.74M | -33.11%14.39M | 39.75%21.52M |
| Net profit before non-cash adjustment | -45.70%1.5M | --445K | -347.99%-1.11M | -63.62%3.52M | --305.63K | --2.77M | --0 | --448K | -36.40%9.68M | -13.03%15.22M |
| Total adjustment of non-cash items | -43.69%2.61M | --2.15M | 21.90%2.92M | 11.98%9.45M | --2.41M | --4.64M | --0 | --2.39M | 38.21%8.44M | 239.32%6.1M |
| -Depreciation and amortization | -31.74%1.82M | --1.77M | 25.51%1.65M | 15.68%5.5M | --1.52M | --2.67M | --0 | --1.31M | 40.20%4.75M | 14.10%3.39M |
| -Reversal of impairment losses recognized in profit and loss | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 6,299,900.00%63K | -100.00%1 |
| -Disposal profit | ---78K | ---51K | --0 | -120.18%-10K | ---10K | --0 | --0 | --0 | 37.49%49.54K | 101.02%36.03K |
| -Net exchange gains and losses | -287.50%-135K | --10K | 142.86%6K | 135.51%17.41K | ---40.59K | --72K | --0 | ---14K | -255.59%-49.02K | 131.17%31.51K |
| -Other non-cash items | -47.09%1.01M | --424K | 15.45%1.26M | 8.88%3.94M | --943.72K | --1.91M | --0 | --1.09M | 36.77%3.62M | 16.80%2.65M |
| Changes in working capital | -481.61%-1.7M | ---1.09M | -5.33%853K | 306.59%7.69M | --6.35M | --446K | --0 | --901K | -2,063.94%-3.72M | 104.86%189.64K |
| -Change in receivables | -296.40%-1.09M | ---762K | 138.29%1.36M | 153.10%1.78M | --650.42K | --556K | --0 | --572K | -835.80%-3.35M | 162.50%455.18K |
| -Change in inventory | 157.01%61K | ---1K | 38.60%79K | -96.26%7K | --57K | ---107K | --0 | --57K | 773.53%187.1K | 99.10%-27.78K |
| -Change in payables | -20,166.67%-608K | ---302K | -316.54%-589K | 1,150.68%5.91M | --5.64M | ---3K | --0 | --272K | -136.54%-562.38K | -142.72%-237.75K |
| -Changes in other current assets | ---63K | ---- | ---- | --0 | --0 | --0 | ---- | ---- | --0 | --0 |
| Dividends paid (cash flow from operating activities) | ||||||||||
| Dividends received (cash flow from operating activities) | ||||||||||
| Interest paid (cash flow from operating activities) | ||||||||||
| Interest received (cash flow from operating activities) | ||||||||||
| Tax refund paid | 95.50%-83K | -238K | 26.29%-185K | 14.57%-2.18M | -90.5K | -1.84M | 0 | -251K | 9.51%-2.56M | -42.93%-2.83M |
| Other operating cash inflow (outflow) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating cash flow | -61.22%2.33M | --1.27M | -29.13%2.47M | 56.11%18.48M | --8.98M | --6.01M | --0 | --3.49M | -36.67%11.84M | 39.28%18.69M |
| Investing cash flow | ||||||||||
| Net PPE purchase and sale | -36.62%-858K | ---935K | -271.86%-978K | 15.02%-6.54M | ---5.65M | ---628K | --0 | ---263K | -86.33%-7.69M | -176.54%-4.13M |
| Net business purchase and sale | --0 | ---62K | ---2.06M | ---2.07M | ---1.66M | ---414K | --0 | --0 | --0 | -45.02%424.88K |
| Net investment property transactions | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | --0 |
| Dividends received (cash flow from investment activities) | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- |
| Interest received (cash flow from investment activities) | -60.84%103K | --95K | 11,300.00%114K | 6,325.99%388.97K | --124.97K | --263K | --0 | --1K | 4,520.61%6.05K | --131 |
| Net changes in other investments | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 98.87%-18.37K | -184.34%-1.63M |
| Investing cash flow | 3.08%-755K | ---902K | -1,014.89%-2.92M | -6.91%-8.22M | ---7.18M | ---779K | --0 | ---262K | -107.55%-7.69M | -160.06%-3.7M |
| Financing cash flow | ||||||||||
| Net issuance payments of debt | 127.93%2.99M | --1.87M | 140.19%520K | -2,469.59%-12.89M | ---906.9K | ---10.69M | --0 | ---1.29M | -5.28%-501.56K | -1,028.21%-476.42K |
| Net common stock issuance | ---- | ---- | ---- | --26M | --1.25M | --0 | ---- | ---- | --0 | ---- |
| Increase or decrease of lease financing | 39.63%-1.77M | ---1.76M | -12.21%-1.65M | -4.33%-5.97M | ---1.56M | ---2.93M | --0 | ---1.47M | -29.62%-5.72M | -47.77%-4.41M |
| Issuance fees | ---- | ---- | ---- | ---1.25M | ---- | ---- | ---- | ---- | --0 | ---- |
| Cash dividends paid | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 80.00%-800K |
| Interest paid (cash flow from financing activities) | -37.15%-3.05M | ---520K | -25.43%-1.38M | -20.74%-4.39M | ---1.07M | ---2.22M | --0 | ---1.1M | -36.90%-3.63M | -16.81%-2.65M |
| Net other fund-raising expenses | --0 | ---5K | --39K | ---- | ---- | ---- | ---- | ---- | ---- | 96.07%-259.26K |
| Financing cash flow | -120.55%-1.83M | ---415K | 36.07%-2.47M | 115.27%1.51M | ---3.54M | --8.91M | --0 | ---3.87M | -14.56%-9.86M | 45.89%-8.6M |
| Net cash flow | ||||||||||
| Beginning cash position | 98.97%18.95M | 99.43%18.99M | 115.82%21.9M | -35.80%10.15M | --23.62M | --9.52M | --9.52M | --10.15M | 67.10%15.81M | 66.45%9.46M |
| Current changes in cash | -101.80%-254K | ---48K | -358.81%-2.92M | 306.15%11.77M | ---1.74M | --14.14M | --0 | ---636K | -189.40%-5.71M | 73.11%6.38M |
| Effect of exchange rate changes | 371.15%141K | --4K | -27.27%8K | -120.47%-9.63K | --31.37K | ---52K | --0 | --11K | 231.83%47.06K | -140.12%-35.7K |
| End cash Position | -20.23%18.84M | 98.97%18.95M | 99.43%18.99M | 115.83%21.9M | --21.9M | --23.62M | --9.52M | --9.52M | -35.80%10.15M | 67.10%15.81M |
| Free cash flow | -75.30%1.33M | --197K | -53.66%1.5M | 205.55%11.93M | --3.32M | --5.39M | --0 | --3.23M | -72.57%3.9M | 44.71%14.24M |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.